The US Peptic Ulcer Drugs Market is currently undergoing a transformation, with its market share poised to experience substantial growth over the coming years. By 2035, the market is set to expand to $1.78 billion, reflecting a compound annual growth rate (CAGR) of 4.22%. This growth is largely driven by an increasing prevalence of peptic ulcers and rising awareness surrounding gastrointestinal...